Cas No.: | 891025-25-5 |
Chemical Name: | Benzamide, N-1,2-benzisoxazol-3-yl-4-methyl- |
Synonyms: | ITPKA-IN-C14,BAMB-4,BAMB4,BAMB 4 |
SMILES: | O=C(C1=CC=C(C)C=C1)NC2=NOC3=CC=CC=C23 |
Formula: | C15H12N2O2 |
M.Wt: | 252.268 |
Description: | BAMB-4(ITPKA-IN-C14) is a new membrane-permeable inhibitor against inositol-1,4,5-trisphosphate-3-kinase A((ITPKA) with IC50 of 37 uM in ADP-Glo Assay.BAMB-4 exhibit the lowest inhibition frequency among the InsP3-Kinase inhibitors. only in one from 42 targets tested,BAMB-4 showed an inhibitory effect. Noteworthy, in kinasescreens no targets of BAMB-4 were detected, indicating that thecompound does not belong to the typical kinase inhibitors. Thus,the relative high speci?city and the high cellular uptake ofBAMB-4 now for the ?rst provide the possibility to effectively inhibit InsP3kinase in vivo. e InsP3Kinase activity is essentially involved in ITPKA promoted metastasis of lung cancer cells, BAMB-4 is a promising therapeutic approach in lung cancertherapy. |
Target: | IC50 value: 37 uM Target: ITPKA inhibitor |
References: | [1]. Schroder D, et al. Identification of a new membrane-permeable inhibitor against inositol-1,4,5-trisphosphate-3-kinase A. Biochem Biophys Res Commun. 2013 Sep 20;439(2):228-34. |